The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) is constructing a 950,000-sf replacement facility at Fort Detrick, Md. The $800 million project will provide BSL-2, BSL-3, and BSL-4 laboratory space to support advanced biomedical research. The U.S. Army Corps of Engineers began construction on the project in August of 2009 and completion is expected in 2017.
SUNY Upstate Medical Center began construction in June of 2015 on the second phase of the Central New York Biotech Accelerator (CNYBAC) in Syracuse, N.Y. Designed by The S/L/A/M Collaborative, the project includes the build out of the second and third floors of the facility to house the Upstate Medical Innovation and Novel Discovery Center (MIND) and the Molecular Pathology Next Generation Sequencing Lab.
In an era of shrinking research funding and growing reliance on complex technologies, a centralized core model resolves a host of issues faced by sizable institutions like University Health Network (UHN) in Toronto, Canada’s largest research hospital.
The University of Maryland is building a state-of-the-art engineering teaching and research building for the era of convergence science. It is designed to facilitate the practical integration of bioscience, medicine, and engineering to develop new biomedical devices and other health-related advancements. When it opens in 2017, the six-floor, 184,000-sf A. James Clark Hall will serve as a national center for innovation that combines engineering with biology, medicine, and information technology in support of private and government partnerships.
Frontage Labs opened a 36,000-sf clinical research center in Secaucus in July of 2015. Designed by DMR Architects, the facility provides a biomedical laboratory, 160 observation beds, exam rooms, administrative offices, dining facilities, a recreation center, and a pharmacy. The project was developed by retrofitting an existing building to meet the specifications of Frontage Labs, an early-stage drug development company based in Exton, Pa.
llumina is partnering with BioMed Realty Trust to develop a 155,000-sf research center in Cambridge in the United Kingdom. Supporting the creation of advanced biopharmaceutical and bioinformatics technologies, the leased facility is designed for ease of expansion, enabling the project to grow by 70,000 sf to provide a total of 225,000 sf of collaborative lab and office space. Illumina is headquartered in San Diego.
Bristol-Myers Squibb will begin construction in July of 2015 on a new research and development facility in Cambridge, Mass. Providing collaborative laboratories and offices for the creation of advanced biomedical and pharmaceutical products, the sustainably designed project comprises 208,000 sf of leased space in the Alexandria Center at Kendall Square development. Completion is expected in late 2017.
Funded by a grant from National Institutes of Health, The Ohio State University renovated Goss Laboratory to create an open lab concept in a 1961 building, where the researchers’ labs previously were isolated from each other. The intent was to promote visibility and teamwork in the field of veterinary infectious disease research. The new design features flexible lab bays lit with natural light, four BSL-2 tissue culture labs, a BSL-2 dedicated rodent phenotyping and infectious necropsy laboratory, equipment rooms, and an open office workspace for graduate student collaboration.
Michigan State University broke ground in June of 2015 on an $88.1 million biomedical research facility in the Grand Rapids Innovation Park. The six-story, 162,800-sf project will provide the College of Human Medicine with open labs to support up to 44 research teams. Designed by SmithGroupJJR with Ellenzweig as laboratory design consultant, the facility will feature core labs for flow cytometry, bioinformatics, microscopy, and long-term storage.
A new 650,000-sf, $295 million complex in Portland, Oregon, consists of the 12-story Skourtes Tower and five-story Collaborative Life Sciences Building (CLSB), which are connected by an atrium nicknamed the “mixing bowl” because it brings everyone together in a central location. The complex supports an interprofessional, multi-institutional program for medicine, nursing, allied health, dentistry, and undergraduate sciences, as well as pure research.
The Wellcome Trust Sanger Institute will open a $42 million genome sequencing facility in August of 2015 in Hinxton in the United Kingdom. The three-story, 51,667-sf project is located near Cambridge on the Institute's biomedical research campus. The sequencing facility is an integral part of the master plan for the site, which will include a 38,750-sf bio-data innovation center. The Sanger Institute is operated by Genome Research Limited, a wholly owned subsidiary of the Wellcome Trust.
The University of Glasgow began construction in fall of 2015 on the $25 million Imaging Centre of Excellence at the South Glasgow Hospitals Campus in Scotland. Designed by BMJ Architects, the project includes redevelopment of an existing building to provide advanced medical research space for neurological and cardiovascular conditions and will feature a 7-Tesla clinical MRI scanner.
Green Cross Biotherapeutics began building a $256 million biopharmaceutical manufacturing facility in Canada in June of 2015. Located on the Montreal Technoparc's Saint-Laurent Campus, the project will support the production of intravenous immunoglobulin (IVIG) and albumin products, and will act as the company's North American headquarters. The 225,000-gsf facility is expected to be fully operational in 2019 and will accommodate 200 scientists, engineers, and support staff. Green Cross Biotherapeutics is headquartered Yongin, South Korea.
Cincinnati Children's Hospital opened the $205 million Clinical Sciences Pavilion in June of 2015. The 15-story, 445,000-sf translational research tower will house over 1,500 scientists, clinicians, and staff engaged in the application of medical discoveries to patient care. The facility features a three-story atrium, a clinical trials center, advanced imaging suites, and laboratories and offices arranged in research neighborhoods to foster interaction and collaboration. Construction began on the pavilion in 2012.
In response to evolving needs and changing research emphases, a major addition to the Institute for Human Performance (IHP) at the State University of New York (SUNY) Upstate Medical University expands the research focus beyond human activity and rehabilitation to encompass exploration of disorders of the nervous system, including behavioral disorders, such as ADHD; diseases of the eye; and neurodegenerative diseases, such as ALS, Alzheimer’s, and Parkinson’s.
